PDGFB and glioblastoma: The results of preclinical experiments showed that PLX3397 has a good inhibitory effect against GBMs driven by platelet-derived growth factor subunit B (PDGFB); however, PLX3397 promotes RAS-driven GBM growth and has no effect on other mesenchymal or pre-neural subtypes75.